Today XXII was featured in breaking news stories in the WSJ and the NYTIMES. Should be a major catalyst... but who knows!
Biden Administration Targets Removal of Most Nicotine From Cigarettes -- WSJ
"...22nd Century Group Inc., a Buffalo-based biotechnology company, uses genetic engineering to grow tobacco with about 95% less nicotine than a typical tobacco plant for a cigarette brand called VLN. The product is currently available for sale in Chicago. 22nd Century has also supplied more than 30 million cigarettes at varying nicotine levels for scientific research.
22nd Century is willing to partner with other cigarette companies to provide tobacco seeds, Chief Executive James Mish said. "It's immediately scalable," he said."
-----------------------
www.nytimes.com/2022...tine-cigarettes.html
F.D.A. Aims to Cut Down on Smoking by Slashing Nicotine Levels in Cigarettes
"Low-nicotine cigarettes are already available to consumers, albeit in a limited fashion. This spring, a New York plant biotech company, 22nd Century Group, began selling a reduced-nicotine cigarette that took 15 years and tens of millions of dollars to develop through the genetic manipulation of the tobacco plant. The company’s brand, VLN, contains 5 percent of the nicotine level of conventional cigarettes, according to James Mish, the company’s chief executive.
“This is not some far-off technology,” he said.
To earn its F.D.A. designation as a “reduced-risk” tobacco product, VLN was subjected to a raft of testing and clinical trials by regulators.
For now, the company is selling VLN at Circle K convenience stores in Chicago as part of a pilot program. Mr. Mish described sales as “modest” — retail prices are similar to premium brands like Marlboro Gold — but he said the F.D.A. proposal would most likely accelerate plans for a national rollout in the coming months."
Biden Administration Targets Removal of Most Nicotine From Cigarettes -- WSJ
"...22nd Century Group Inc., a Buffalo-based biotechnology company, uses genetic engineering to grow tobacco with about 95% less nicotine than a typical tobacco plant for a cigarette brand called VLN. The product is currently available for sale in Chicago. 22nd Century has also supplied more than 30 million cigarettes at varying nicotine levels for scientific research.
22nd Century is willing to partner with other cigarette companies to provide tobacco seeds, Chief Executive James Mish said. "It's immediately scalable," he said."
-----------------------
www.nytimes.com/2022...tine-cigarettes.html
F.D.A. Aims to Cut Down on Smoking by Slashing Nicotine Levels in Cigarettes
"Low-nicotine cigarettes are already available to consumers, albeit in a limited fashion. This spring, a New York plant biotech company, 22nd Century Group, began selling a reduced-nicotine cigarette that took 15 years and tens of millions of dollars to develop through the genetic manipulation of the tobacco plant. The company’s brand, VLN, contains 5 percent of the nicotine level of conventional cigarettes, according to James Mish, the company’s chief executive.
“This is not some far-off technology,” he said.
To earn its F.D.A. designation as a “reduced-risk” tobacco product, VLN was subjected to a raft of testing and clinical trials by regulators.
For now, the company is selling VLN at Circle K convenience stores in Chicago as part of a pilot program. Mr. Mish described sales as “modest” — retail prices are similar to premium brands like Marlboro Gold — but he said the F.D.A. proposal would most likely accelerate plans for a national rollout in the coming months."